FDA Approves Novel Drug to Treat Moderate to Severe Hot Flashes Caused by Menopause ...Middle East

SILVER SPRING, Md., May 12, 2023 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Veozah (fezolinetant), an oral medication for the treatment of moderate to severe vasomotor symptoms, or hot flashes, caused by menopause. Veozah is the first neurokinin 3 (NK3) receptor...

Hence then, the article about fda approves novel drug to treat moderate to severe hot flashes caused by menopause was published today ( Friday 12/05/2023 - 09:17 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves Novel Drug to Treat Moderate to Severe Hot Flashes Caused by Menopause )

Also on site :

• CholaNad Owner Arrested For Attempted Murder; Restaurant Temporarily Closed
• Water Bill Rate Hike Map: Where 300,000 Could Pay Hundreds More in Missouri
• Video: Moment hikers get caught in Guatemala volcano eruption